The sensitivity of CEA for detection of CRC was 30.61%, which was significantly lower than those of the novel evaluation by KRAS mutation, BMP3 and NDRG4 methylation, and FOB, while the specificity of CEA was 75.16%. This evidence concerns the gene KRAS and colorectal carcinoma.